Internal Medicine, Infectious Disease · Cleveland, OH
NPI
1750346953
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
9500 Euclid Ave
Cleveland, OH, 44195
Phone (800) 223-2273
Groups this clinician bills Medicare through
Medicare paid, 2024
$38K
573 services
Medicare patients, 2024
132
Average age 71
Drug cost, 2024
$259K
685 prescriptions
Company payments, 2025
$146
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven K Schmitt was code 99232 (hospital e&m - subsequent), 305 times for 80 patients. In total Steven K Schmitt billed 573 services in 11 codes, and Medicare paid $38K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-02-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 305 | 80 | $59.26 | $18K |
| 99233 Hospital E&M - Subsequent | Facility | 116 | 68 | $88.83 | $10K |
| 99213 Office E&M - Established | Office | 44 | 30 | $61.44 | $2,704 |
| 99222 Hospital E&M - Initial | Facility | 28 | 27 | $95.37 | $2,670 |
| 99213 Office E&M - Established | Facility | 24 | 20 | $45.63 | $1,095 |
| 99214 Office E&M - Established | Facility | 13 | 11 | $73.53 | $956 |
By year: 2022 $45K for 722 services; 2023 $40K for 586 services; 2024 $38K for 573 services.
Medicare prescription drug claims, 2024
In 2024, the drug Steven K Schmitt prescribed most often to Medicare patients was Doxycycline Monohydrate, with 77 prescriptions and refills. In total Steven K Schmitt wrote 685 Medicare prescriptions that cost $259K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Doxycycline Monohydrate Generic | 77 | 102 | 19 | $2,304 |
| Amoxicillin Generic | 72 | 115 | 17 | $457 |
| Vancomycin Hcl Generic | 70 | 70 | 20 | $13K |
| Cephalexin Generic | 62 | 78 | Under 11 | $1,325 |
| Dicloxacillin Sodium Generic | 49 | 51 | Under 11 | $3,244 |
| Clindamycin Hcl Generic | 40 | 81 | Under 11 | $771 |
| Cefazolin Sodium Generic | 29 | 29 | Under 11 | $997 |
| Ampicillin Sodium Generic | 26 | 26 | Under 11 | $4,451 |
| Doxycycline Hyclate Generic | 25 | 37 | Under 11 | $470 |
| Ertapenem Ertapenem Sodium | 24 | 24 | Under 11 | $7,784 |
| Daptomycin Generic | 22 | 22 | Under 11 | $15K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 21 | 37 | Under 11 | $231 |
| Fluconazole Generic | 16 | 32 | Under 11 | $836 |
| Ceftriaxone Ceftriaxone Sodium | 15 | 15 | Under 11 | $776 |
| Sivextro Tedizolid Phosphate | 15 | 15 | Under 11 | $185K |
Brand drugs: 53 claims; generic drugs: 632 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven K Schmitt $146 ($146 in general payments such as food, travel and fees) from 1 company. The largest payer was La Jolla Pharmaceutical Company with $146.
| Company | Payments | Amount |
|---|---|---|
| La Jolla Pharmaceutical Company | 1 | $146 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.